These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 20625232)
1. Effects of docosahexaenoic acid in an experimental rat model of nonalcoholic steatohepatitis. Takayama F; Nakamoto K; Totani N; Yamanushi T; Kabuto H; Kaneyuki T; Mankura M J Oleo Sci; 2010; 59(8):407-14. PubMed ID: 20625232 [TBL] [Abstract][Full Text] [Related]
2. Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis. Depner CM; Philbrick KA; Jump DB J Nutr; 2013 Mar; 143(3):315-23. PubMed ID: 23303872 [TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice. Lytle KA; Wong CP; Jump DB PLoS One; 2017; 12(4):e0173376. PubMed ID: 28422962 [TBL] [Abstract][Full Text] [Related]
4. Effects of treatment with hydrogen sulfide on methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats. Luo ZL; Tang LJ; Wang T; Dai RW; Ren JD; Cheng L; Xiang K; Tian FZ J Gastroenterol Hepatol; 2014 Jan; 29(1):215-22. PubMed ID: 24117897 [TBL] [Abstract][Full Text] [Related]
5. Soy protein retards the progression of non-alcoholic steatohepatitis via improvement of insulin resistance and steatosis. Yang HY; Tzeng YH; Chai CY; Hsieh AT; Chen JR; Chang LS; Yang SS Nutrition; 2011 Sep; 27(9):943-8. PubMed ID: 21333494 [TBL] [Abstract][Full Text] [Related]
6. The vitamin E reduces liver lipoperoxidation and fibrosis in a model of nonalcoholic steatohepatitis. Zamin I; Mattos AA; Mattos AZ; Coral G; Santos D; Rhoden C Arq Gastroenterol; 2010; 47(1):86-92. PubMed ID: 20520981 [TBL] [Abstract][Full Text] [Related]
7. Protective effects of various ratios of DHA/EPA supplementation on high-fat diet-induced liver damage in mice. Shang T; Liu L; Zhou J; Zhang M; Hu Q; Fang M; Wu Y; Yao P; Gong Z Lipids Health Dis; 2017 Mar; 16(1):65. PubMed ID: 28356106 [TBL] [Abstract][Full Text] [Related]
8. DHA supplementation prevent the progression of NASH via GPR120 signaling. Nakamoto K; Shimada K; Harada S; Morimoto Y; Hirasawa A; Tokuyama S Eur J Pharmacol; 2018 Feb; 820():31-38. PubMed ID: 29221950 [TBL] [Abstract][Full Text] [Related]
9. Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice. Honda T; Ishigami M; Luo F; Lingyun M; Ishizu Y; Kuzuya T; Hayashi K; Nakano I; Ishikawa T; Feng GG; Katano Y; Kohama T; Kitaura Y; Shimomura Y; Goto H; Hirooka Y Metabolism; 2017 Apr; 69():177-187. PubMed ID: 28285648 [TBL] [Abstract][Full Text] [Related]
10. Comparative effect of pioglitazone, quercetin and hydroxy citric acid on the status of lipid peroxidation and antioxidants in experimental non-alcoholic steatohepatitis. Surapaneni KM; Jainu M J Physiol Pharmacol; 2014 Feb; 65(1):67-74. PubMed ID: 24622831 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease. Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885 [TBL] [Abstract][Full Text] [Related]
12. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis. Salamone F; Galvano F; Cappello F; Mangiameli A; Barbagallo I; Li Volti G Transl Res; 2012 Jun; 159(6):477-86. PubMed ID: 22633099 [TBL] [Abstract][Full Text] [Related]
13. Hepatoprotective effects of geniposide in a rat model of nonalcoholic steatohepatitis. Ma T; Huang C; Zong G; Zha D; Meng X; Li J; Tang W J Pharm Pharmacol; 2011 Apr; 63(4):587-93. PubMed ID: 21401612 [TBL] [Abstract][Full Text] [Related]
14. Food-derived peroxidized fatty acids may trigger hepatic inflammation: a novel hypothesis to explain steatohepatitis. Böhm T; Berger H; Nejabat M; Riegler T; Kellner F; Kuttke M; Sagmeister S; Bazanella M; Stolze K; Daryabeigi A; Bintner N; Murkovic M; Wagner KH; Schulte-Hermann R; Rohr-Udilova N; Huber W; Grasl-Kraupp B J Hepatol; 2013 Sep; 59(3):563-70. PubMed ID: 23665282 [TBL] [Abstract][Full Text] [Related]
16. Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis. Uno M; Kurita S; Misu H; Ando H; Ota T; Matsuzawa-Nagata N; Kita Y; Nabemoto S; Akahori H; Zen Y; Nakanuma Y; Kaneko S; Takamura T Hepatology; 2008 Jul; 48(1):109-18. PubMed ID: 18571789 [TBL] [Abstract][Full Text] [Related]
17. Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats. Yang ZR; Wang HF; Zuo TC; Guan LL; Dai N BMC Pharmacol Toxicol; 2016 Apr; 17():16. PubMed ID: 27075663 [TBL] [Abstract][Full Text] [Related]
18. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis. Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126 [TBL] [Abstract][Full Text] [Related]
19. Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis. Jung YA; Choi YK; Jung GS; Seo HY; Kim HS; Jang BK; Kim JG; Lee IK; Kim MK; Park KG Diabetes Res Clin Pract; 2014 Jul; 105(1):47-57. PubMed ID: 24842243 [TBL] [Abstract][Full Text] [Related]
20. Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model. Matsunami T; Sato Y; Ariga S; Sato T; Shimomura T; Kashimura H; Hasegawa Y; Yukawa M Metabolism; 2011 Jun; 60(6):805-14. PubMed ID: 20846698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]